Ligand Pharmaceuticals Incorporated - Common Stock (LGND)

Ligand Pharmaceuticals is a biopharmaceutical company that focuses on the development of innovative therapies and treatments by leveraging its proprietary drug discovery technologies and a diverse portfolio of drug candidates

The company primarily collaborates with other pharmaceutical and biotechnology firms to discover and advance new medications, particularly in areas such as oncology, cardiovascular diseases, and metabolic disorders. Through its unique platform, Ligand aims to enhance drug efficacy and streamline the development process, contributing to the advancement of healthcare solutions that improve patient outcomes.